Moreover, HBOC increases the likelihood of multifocal and synchronous breast cancers; in a cohort of BRCA carriers, MF/MC disease occurred in 25% overall and was more than twice as frequent in BRCA2 than in BRCA1 [15]. This evidence concerns the gene BRCA2 and breast carcinoma.